Survival analysis indicated that the expression levels of CCNA2, CHK1, E2F1, and TOP2A are significantly associated with the survival prognosis of hepatocellular carcinoma patients, with p-values of 0.0038, 0.00013, 0.013, and 0.00066, respectively. This evidence concerns the gene CCNA2 and hepatocellular carcinoma.